Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yan Chen, Jiafei Cheng, Yiling Zhang, Jiande D Z Chen & Florin M Seralu. (2021) Electroacupuncture at ST36 Relieves Visceral Hypersensitivity via the NGF/TrkA/TRPV1 Peripheral Afferent Pathway in a Rodent Model of Post-Inflammation Rectal Hypersensitivity. Journal of Inflammation Research 14, pages 325-339.
Read now
Read now
David J Gracie & Alexander C Ford. (2015) IBS-like symptoms in patients with ulcerative colitis. Clinical and Experimental Gastroenterology 8, pages 101-109.
Read now
Read now
Peter LM Jansen. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:7-8, pages 771-772.
Read now
Read now
Articles from other publishers (45)
Hanna Öhlmann, Laura Ricarda Lanters, Nina Theysohn, Jost Langhorst, Harald Engler, Adriane Icenhour & Sigrid Elsenbruch. (2023) Distinct Alterations in Central Pain Processing of Visceral and Somatic Pain in Quiescent Ulcerative Colitis Compared to Irritable Bowel Syndrome and Health. Journal of Crohn's and Colitis 17:10, pages 1639-1651.
Crossref
Crossref
Georgiana-Emmanuela Gîlcă-Blanariu, Cristina Gabriela Șchiopu, Gabriela Ștefănescu, Cătălina Mihai, Smaranda Diaconescu, Vlad Adrian Afrăsânie, Vasile Valeriu Lupu, Ancuța Lupu, Alexandra Boloș & Cristinel Ștefănescu. (2023) The Intertwining Roads between Psychological Distress and Gut Microbiota in Inflammatory Bowel Disease. Microorganisms 11:9, pages 2268.
Crossref
Crossref
Brigida Barberio, David J Gracie, Christopher J Black & Alexander C Ford. (2023) Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn’s Disease: Meta-analysis. Inflammatory Bowel Diseases.
Crossref
Crossref
Jay Pravda. (2022) Evidence-based pathogenesis and treatment of ulcerative colitis: A causal role for colonic epithelial hydrogen peroxide. World Journal of Gastroenterology 28:31, pages 4263-4298.
Crossref
Crossref
Haiyang Wang, Xiaojing Zhao, Xiufang Cui, Meifeng Wang, Chunhua Jiao, Jiajia Li, Yan Yang, Yi Li & Hongjie Zhang. (2021) A Pilot Study of Clinical Evaluation and Formation Mechanism of Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease Patients in Remission. Journal of Neurogastroenterology and Motility 27:4, pages 612-625.
Crossref
Crossref
Hanna Tufvesson, Julia Dreja, Olle Ekberg, Peter Leander, Sven Månsson & Bodil Ohlsson. (2020) Quantified small bowel motility in patients with ulcerative colitis and gastrointestinal symptoms: a pilot study. Acta Radiologica 62:7, pages 858-866.
Crossref
Crossref
Andrés Hurtado-Lorenzo, Gerard Honig, Sarah Alandra Weaver, Paul B Larkin & Caren Heller. (2021) Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize Treatment and Improve Clinical Outcomes. Crohn's & Colitis 360 3:3.
Crossref
Crossref
Bastian Schirmer & Detlef Neumann. (2021) The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut. International Journal of Molecular Sciences 22:11, pages 6116.
Crossref
Crossref
Yan Chen, Yu Guo, Payam Gharibani, Jie Chen, Florin M. Selaru & Jiande D. Z. Chen. (2021) Transitional changes in gastrointestinal transit and rectal sensitivity from active to recovery of inflammation in a rodent model of colitis. Scientific Reports 11:1.
Crossref
Crossref
Georgios Mavroudis, Hans Strid, Börje Jonefjäll & Magnus Simrén. (2020) Visceral hypersensitivity is together with psychological distress and female gender associated with severity of IBS‐like symptoms in quiescent ulcerative colitis. Neurogastroenterology & Motility 33:3.
Crossref
Crossref
Imran Aziz & Magnus Simrén. (2021) The overlap between irritable bowel syndrome and organic gastrointestinal diseases. The Lancet Gastroenterology & Hepatology 6:2, pages 139-148.
Crossref
Crossref
Spyros Peppas, Claudia Pansieri, Daniele Piovani, Silvio Danese, Laurent Peyrin-Biroulet, Andreas G. Tsantes, Enrico Brunetta, Argirios E. Tsantes & Stefanos Bonovas. (2021) The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases. Journal of Clinical Medicine 10:3, pages 377.
Crossref
Crossref
Matthew D. Coates, Ansh Johri, Venkata Subhash Gorrepati, Parth Maheshwari, Shannon Dalessio, Vonn Walter, August Stuart, Walter Koltun, Nana Bernasko, Andrew Tinsley, Emmanuelle D. Williams & Kofi Clarke. (2020) Abdominal pain in quiescent inflammatory bowel disease. International Journal of Colorectal Disease 36:1, pages 93-102.
Crossref
Crossref
Sanaz Soleymani, Azadeh Moradkhani, Masoumeh Eftekhari, Fatemeh Rahmanian & Seyed Hamid Moosavy. (2020) Correlation between Clinical Symptoms and Lab Tests with Endoscopic Severity Indexes in Patients with Inflammatory Bowel Diseases. Middle East Journal of Digestive Diseases 12:3, pages 162-170.
Crossref
Crossref
Antonina Mikocka-Walus, Alexander C. Ford & Douglas A. Drossman. (2020) Antidepressants in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 17:3, pages 184-192.
Crossref
Crossref
Selina R. Cox, James O. Lindsay, Sébastien Fromentin, Andrew J. Stagg, Neil E. McCarthy, Nathalie Galleron, Samar B. Ibraim, Hugo Roume, Florence Levenez, Nicolas Pons, Nicolas Maziers, Miranda C. Lomer, S. Dusko Ehrlich, Peter M. Irving & Kevin Whelan. (2020) Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology 158:1, pages 176-188.e7.
Crossref
Crossref
Nicolas Esquerre, Lilian Basso, Manon Defaye, Fernando A. Vicentini, Nina Cluny, Dominique Bihan, Simon A. Hirota, Alana Schick, Humberto B. Jijon, Ian A. Lewis, Markus B. Geuking, Keith A. Sharkey, Christophe Altier & Yasmin Nasser. (2020) Colitis-Induced Microbial Perturbation Promotes Postinflammatory Visceral Hypersensitivity. Cellular and Molecular Gastroenterology and Hepatology 10:2, pages 225-244.
Crossref
Crossref
Zhili Xu, Mingbo Zhang, Deqiang Dou, Tingguo Kang & Feng Li. (2019) Effects of Deoxyschisandrin on Visceral Sensitivity of Mice with Inflammatory Bowel Disease. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-9.
Crossref
Crossref
A. A. SheptulinK. E. Vinogradskaya. (2019) Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?. Russian Journal of Gastroenterology, Hepatology, Coloproctology 29:5, pages 43-48.
Crossref
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Crossref
Yoshiharu Uno. (2019) Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. Medical Hypotheses 132, pages 109324.
Crossref
Crossref
Wenting Zhong, Xiaolan Lu, Haitao Shi, Gang Zhao, Yahua Song, Yonghua Wang, Jing Zhang, Yaofeng Jin & Shenhao Wang. (2019) Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis. Journal of Clinical Gastroenterology 53:9, pages 660-672.
Crossref
Crossref
David J Gracie, P John Hamlin & Alexander C Ford. (2019) The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment. The Lancet Gastroenterology & Hepatology 4:8, pages 632-642.
Crossref
Crossref
Kata Csekő, Bram Beckers, Daniel Keszthelyi & Zsuzsanna Helyes. (2019) Role of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?. Pharmaceuticals 12:2, pages 48.
Crossref
Crossref
Jean-Frederic Colombel, Andrea Shin & Peter R. Gibson. (2019) AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clinical Gastroenterology and Hepatology 17:3, pages 380-390.e1.
Crossref
Crossref
Juan Wan, Yi Ding, Adnan H. Tahir, Manoj K. Shah, Habibullah Janyaro, Xiaojing Li, Juming Zhong, Vitaly Vodyanoy & Mingxing Ding. (2017) Electroacupuncture Attenuates Visceral Hypersensitivity by Inhibiting JAK2/STAT3 Signaling Pathway in the Descending Pain Modulation System. Frontiers in Neuroscience 11.
Crossref
Crossref
Dan Carter, Marc Beer-Gabel, Estela Derazne, Dorit Tzur & Eytan Bardan. (2017) The Severity of Symptoms Related to Irritable Bowel Syndrome is a Risk Factor for the Misclassification of Significant Organic Disease. Journal of Clinical Gastroenterology 51:5, pages 421-425.
Crossref
Crossref
Robin Spiller & Giles Major. (2016) IBS and IBD — separate entities or on a spectrum?. Nature Reviews Gastroenterology & Hepatology 13:10, pages 613-621.
Crossref
Crossref
David J Gracie, Christopher J M Williams, Ruchit Sood, Saqib Mumtaz, Hassan M Bholah, John P Hamlin & Alexander C Ford. (2016) Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease. American Journal of Gastroenterology 111:4, pages 541-551.
Crossref
Crossref
Carlos Teruel. (2016) Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:1, pages 78.
Crossref
Crossref
A. Deiteren, J. G. De Man, C. Keating, W. Jiang, H. U. De Schepper, P. A. Pelckmans, S. M. Francque & B. Y. De Winter. (2015) Mechanisms contributing to visceral hypersensitivity: focus on splanchnic afferent nerve signaling. Neurogastroenterology & Motility 27:12, pages 1709-1720.
Crossref
Crossref
B. Jharap, W. J. Sandborn, W. Reinisch, G. D'Haens, A. M. Robinson, W. Wang, B. Huang, A. Lazar, R. B. Thakkar & J.-F. Colombel. (2015) Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis. Alimentary Pharmacology & Therapeutics 42:9, pages 1082-1092.
Crossref
Crossref
Bastian Schirmer, Thomas Rezniczek, Roland Seifert & Detlef Neumann. (2015) Proinflammatory role of the histamine H4 receptor in dextrane sodium sulfate-induced acute colitis. Biochemical Pharmacology 98:1, pages 102-109.
Crossref
Crossref
Sushil K. Sarna & John H. Winston. (2015) Symptom Generation by Mucosal Inflammation in Irritable Bowel Syndrome. Gastroenterology 149:2, pages 287-289.
Crossref
Crossref
C. Brochard, L. Siproudhis, A. Ropert, A. Mallak, J-F Bretagne & G. Bouguen. (2015) Anorectal dysfunction in patients with ulcerative colitis: impaired adaptation or enhanced perception?. Neurogastroenterology & Motility 27:7, pages 1032-1037.
Crossref
Crossref
Harissios Vliagoftis & A.D. Befus. 2015. Mucosal Immunology. Mucosal Immunology
859
882
.
Matthew J. Hamilton, Sandra M. Frei & Richard L. Stevens. (2014) The Multifaceted Mast Cell in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2364-2378.
Crossref
Crossref
Detlef Neumann & Roland Seifert. (2014) The therapeutic potential of histamine receptor ligands in inflammatory bowel disease. Biochemical Pharmacology 91:1, pages 12-17.
Crossref
Crossref
Giovanni Barbara, Cesare Cremon & Vincenzo Stanghellini. (2014) Inflammatory bowel disease and irritable bowel syndrome. Current Opinion in Gastroenterology 30:4, pages 352-358.
Crossref
Crossref
Kenny Roman, Joseph D. Done, Anthony J. Schaeffer, Stephen F. Murphy & Praveen Thumbikat. (2014) Tryptase-PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndrome. Pain 155:7, pages 1328-1338.
Crossref
Crossref
Ji Yong Ahn, Kyung Hun Lee, Chang Hwan Choi, Ju Wan Kim, Hyun Woong Lee, Jeong Wook Kim, Mi Kyung Kim, Gui Young Kwon, Seungbong Han, Seong-Eun Kim, Sung Min Kim & Sae Kyung Chang. (2013) Colonic Mucosal Immune Activity in Irritable Bowel Syndrome: Comparison with Healthy Controls and Patients with Ulcerative Colitis. Digestive Diseases and Sciences 59:5, pages 1001-1011.
Crossref
Crossref
Gabrio Bassotti, Vincenzo Villanacci, Riccardo Nascimbeni, Elisabetta Antonelli, Moris Cadei, Stefania Manenti, Luisa Lorenzi, Amin Titi & Bruno Salerni. (2012) The role of colonic mast cells and myenteric plexitis in patients with diverticular disease. International Journal of Colorectal Disease 28:2, pages 267-272.
Crossref
Crossref
Stephen J Halpin & Alexander C Ford. (2012) Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. American Journal of Gastroenterology 107:10, pages 1474-1482.
Crossref
Crossref
Arvind Iyengar Srinath, Chelsea Walter, Melissa C. Newara & Eva M. Szigethy. (2012) Pain management in patients with inflammatory bowel disease: insights for the clinician. Therapeutic Advances in Gastroenterology 5:5, pages 339-357.
Crossref
Crossref
Bin Feng, Jun Ho La, Erica S. Schwartz & G. F. Gebhart. (2012) Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 302:10, pages G1085-G1098.
Crossref
Crossref